Cosmo Pharmaceuticals N.V. (FRA: C43)
Germany
· Delayed Price · Currency is EUR 62.50
0.00 (0.00%)
At close: Dec 20, 2024
Cosmo Pharmaceuticals Ratios and Metrics
Market cap in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 19, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Market Capitalization | 1,029 | 879 | 1,015 | 1,065 | 1,136 | 1,032 | Upgrade
|
| Market Cap Growth | 55.18% | -13.35% | -4.77% | -6.21% | 10.07% | -11.83% | Upgrade
|
| Enterprise Value | 899 | 838 | 974 | 1,028 | 1,067 | 868 | Upgrade
|
| Last Close Price | 62.50 | 53.04 | 59.07 | 57.95 | 71.97 | 64.96 | Upgrade
|
| PE Ratio | 14.79 | - | 58.91 | 49.16 | - | - | Upgrade
|
| PS Ratio | 6.31 | 9.48 | 9.94 | 16.37 | 18.64 | 16.51 | Upgrade
|
| PB Ratio | 2.31 | 2.05 | 2.19 | 2.08 | 2.84 | 2.62 | Upgrade
|
| P/TBV Ratio | 11.69 | 20.67 | 14.08 | 9.52 | 2.87 | 2.78 | Upgrade
|
| P/FCF Ratio | 10.25 | 29.04 | 35.34 | 149.55 | 128.14 | - | Upgrade
|
| P/OCF Ratio | 9.96 | 26.15 | 30.54 | 84.48 | 87.48 | - | Upgrade
|
| EV/Sales Ratio | 4.69 | 9.03 | 9.54 | 15.80 | 17.50 | 13.89 | Upgrade
|
| EV/EBITDA Ratio | 8.65 | 42.51 | 23.65 | 57.74 | 176.12 | - | Upgrade
|
| EV/EBIT Ratio | 10.12 | 136.27 | 34.71 | 92.64 | 590.89 | - | Upgrade
|
| EV/FCF Ratio | 7.89 | 27.66 | 33.92 | 144.35 | 120.31 | - | Upgrade
|
| Debt / Equity Ratio | 0.00 | 0.00 | 0.37 | 0.33 | 0.42 | 0.42 | Upgrade
|
| Debt / EBITDA Ratio | 0.01 | 0.09 | 4.14 | 9.20 | 24.49 | - | Upgrade
|
| Debt / FCF Ratio | 0.01 | 0.06 | 6.05 | 23.85 | 18.97 | - | Upgrade
|
| Asset Turnover | 0.27 | 0.14 | 0.13 | 0.09 | 0.10 | 0.10 | Upgrade
|
| Inventory Turnover | 3.19 | 3.06 | 3.29 | 3.50 | 4.66 | 4.97 | Upgrade
|
| Quick Ratio | 4.35 | 3.15 | 1.45 | 11.77 | 11.06 | 18.39 | Upgrade
|
| Current Ratio | 4.85 | 3.98 | 1.57 | 12.99 | 11.60 | 19.25 | Upgrade
|
| Return on Equity (ROE) | 14.80% | -1.06% | 3.59% | 4.75% | -1.99% | -5.84% | Upgrade
|
| Return on Assets (ROA) | 7.82% | 0.58% | 2.24% | 0.99% | 0.19% | -1.27% | Upgrade
|
| Return on Capital (ROIC) | 9.59% | 0.72% | 2.66% | 1.11% | 0.20% | -1.32% | Upgrade
|
| Earnings Yield | 6.91% | -0.56% | 1.70% | 2.03% | -0.70% | -2.37% | Upgrade
|
| FCF Yield | 9.75% | 3.44% | 2.83% | 0.67% | 0.78% | -2.04% | Upgrade
|
| Dividend Yield | 2.87% | 3.77% | 1.78% | 1.64% | - | - | Upgrade
|
| Payout Ratio | 6.07% | - | 90.61% | - | - | - | Upgrade
|
| Buyback Yield / Dilution | 0.77% | 1.95% | 2.83% | -16.81% | 1.11% | 2.48% | Upgrade
|
| Total Shareholder Return | 0.77% | 5.72% | 4.61% | -15.17% | 1.11% | 2.48% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.